During the past decade, Azienda Sanitaria di Bolzano conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Azienda Sanitaria di Bolzano" #1 sponsor was "ETOP IBCSG Partners Foundation" with 3 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials sponsored, "Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy" with 1 trials sponsored, "IRCCS Azienda Ospedaliero-Universitaria di Bologna" with 1 trials sponsored and "Mario Negri Institute for Pharmacological Research" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Azienda Sanitaria di Bolzano" #1 collaborator was "Breast International Group" with 3 trials as a collaborator, "Alliance for Clinical Trials in Oncology" with 1 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator, "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Azienda Sanitaria di Bolzano" are "Breast Cancer" (2 trials), "Bladder Cancer" (1 trials), "Colorectal Cancer" (1 trials), "Early Breast Cancer" (1 trials) and "Endometrial Cancer" (1 trials). Many other conditions were trialed in "Azienda Sanitaria di Bolzano" in a lesser frequency.

Most popular intervention types in "Azienda Sanitaria di Bolzano" are "Drug" (6 trials), "Other" (2 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (1 trials), "Carboplatin" (1 trials), "Clinical information" (1 trials), "Endocrine therapy interruption" (1 trials) and "LSM assessed by Elastographic Techniques" (1 trials). Other intervention names were less common.

The vast majority of trials in "Azienda Sanitaria di Bolzano" are 5 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Azienda Sanitaria di Bolzano". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Azienda Sanitaria di Bolzano, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Azienda Sanitaria di Bolzano, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".

Azienda Sanitaria di Bolzano has several departments that took part in Clinical trials: "Ospedale Di Bolzano; Dept. Di Oncologia" - 6 trials